Why are treatments no longer lucrative? In this investigative documentary, we expose the pharmaceutical market's transition from medical developments to a long-lasting subscription model. From the 1910 Flexner Report to the 2018 Goldman Sachs report, we follow the money to expose how persistent illness ended up being a service method.
TL; DR: Modern medication has actually been rewired to focus on management over remission. This video checks out the historical "education cull" of 1910, the patent thickets of the 1980s, and the vertical monopolies of CVS and Aetna that keep clients secured a cycle of refills.
Stop being a consumer and begin being a patient once again. We're breaking down the engineering of demand through food, the regulatory capture of the FDA, and the "orphan playbook" utilized to escalate drug costs.
In This Video: 0:00 - The 1910 Flexner Report: The Audit That Altered Everything 0:15 - Shocking Claim: Cures are a "Bad Organization Design" 0:30 - The Stakes: Why Your Health is a Membership 10:00 - Constructing the Monopoly: Structures Patents 20:00 - The 1980 Bayh-Dole Act University Profits 30:00 - Persistent Illness as an Organization Model 40:00 - Engineering Demand: The Sugar Food Market Lie 50:00 - The CVS-Aetna Loop: Vertical Combination Exposed 1:00:00 - Removing Alternatives: Why Non-Patent Medication is Marginalized 1:10:00 - Whistleblowers Billion-Dollar Fines 1:20:00 - Precision Subscriptions: The Future of Data-Driven Care 1:30:00 - The Care That Threatens the Model: Turnaround Remission 1:40:00 - Policy Solutions Personal Company
